Ketoconazole Shampoo Hair Loss: What the Small Studies Show

Does ketoconazole shampoo help hair loss?

Possibly a little, but the evidence is thin. Across every published human study, 81 men with pattern hair loss used a ketoconazole shampoo as their only active treatment, and none of them was in a randomised trial against a placebo shampoo. The largest study, 150 men over six months, found shedding fell by 17% with no change in hair density. Finasteride and minoxidil remain the first-line options.

Ketoconazole shampoo for hair loss is one of the most repeated recommendations on the internet. Hair loss forums often call it the third of the "big three" alongside finasteride and minoxidil, and telehealth brands sell it next to both. The shampoo itself is an antifungal, sold to treat dandruff, and it is not approved anywhere as a hair loss treatment.

So the useful question is not "does it work" in the abstract. It is how much evidence exists, who produced it, and what it actually measured. This page answers that study by study, lists the side-effect rates from the labels, and says where the shampoo reasonably fits. If you are not yet sure the loss you are seeing is pattern hair loss at all, the Norwood stage finder is a faster first step than any shampoo.

What the ketoconazole shampoo hair loss studies actually tested

Seven human datasets exist, all of them small, and only three tested a ketoconazole shampoo on its own in people with pattern hair loss. The 2020 systematic review of the topic (Fields et al, Dermatol Ther 2020) found five human studies and two in mice; one further trial, in women, appeared in late 2019 in a journal not indexed in PubMed. A PubMed search for ketoconazole and alopecia, hair loss or hair growth, limited to 2020 through 2026, returns 23 records and no new human trial.

Study	Who	On ketoconazole	Design	What they used	Result
Piérard-Franchimont 1998, study 1 (Dermatology)	39 men, vertex loss	27	Not randomised, unmedicated shampoo control, 21 months	2% shampoo, 2 to 4 times a week	Pilary index (anagen % × shaft diameter) rose from month 6, plateaued after month 15; controls declined
Piérard-Franchimont 1998, study 2 (same paper)	8 men, vertex loss	4	Not randomised, vs 2% minoxidil, 6 months	2% shampoo	Density +18% vs +11% on minoxidil; shaft diameter +7% in both
Piérard-Franchimont 2002 (Int J Cosmet Sci)	150 men, pattern loss plus dandruff-related shedding	50	Randomised vs two other anti-dandruff shampoos, 6 months	1% shampoo, 2 to 3 times a week	Density unchanged; shedding −17.3%
Khandpur 2002 (J Dermatol)	100 men, Hamilton II to IV	10, all also on finasteride	Open randomised, 4 arms, 1 year	2% shampoo, 3 times a week, plus finasteride 1 mg	Second-best arm; no ketoconazole-only arm
Inui and Itami 2007 (J Dermatol Sci)	6 men	6	Case series, no control	2% lotion, not shampoo	3 of 6 improved on photographs
Rafi and Katz 2011 (ISRN Dermatol)	15 men	10, all also on other drugs	Uncontrolled pilot	2% shampoo as optional add-on	All 15 grew hair; nobody used ketoconazole alone
El-Garf 2019 (Biomed Dermatol)	40 women, female pattern loss	20	Randomised vs 2% minoxidil, 6 months	"2% topical ketoconazole preparation"	Minoxidil improved by month 4, ketoconazole only by month 6

Add the rows up and 127 people with pattern hair loss have used ketoconazole in any form in a published study. Take out the lotion, the leave-on preparation and the men who were also on finasteride or dutasteride, and 81 men used a ketoconazole shampoo as their only active treatment: 27, then 4, then 50.

For scale, the two vertex registration trials for finasteride randomised 1,553 men against placebo, double-blind, and measured hair counts in a marked circle of scalp. The full milestone data sits on our finasteride results page. The ketoconazole literature has nothing comparable, and the PubMed search above found no new human trial after 2019.

Four claims that do not match their source

The most repeated ketoconazole numbers online are real numbers from real papers, but most of them describe something narrower than the claim built on top. Here is each one next to what the source says.

"Ketoconazole works about as well as minoxidil." This comes from study 2 of the 1998 paper: four men on ketoconazole shampoo against four men on 2% minoxidil lotion, not randomised, with hair shaft measurements taken from scalp biopsies. The shampoo group's density rose 18% against 11%. Eight men cannot establish equivalence to anything, and the comparison was with 2% minoxidil, not the 5% strength men use today. The authors themselves wrote that the clinical significance "awaits further controlled study in a larger group of subjects." Two of the paper's four authors, Piet De Doncker and Geert Cauwenbergh, had run clinical research at Janssen, the company that developed ketoconazole, where Cauwenbergh led Nizoral to become "a global market leader" (profile of Cauwenbergh's Janssen career). That does not make the data wrong, but it is relevant context for a small, non-randomised result.

"68% of users saw increased density." The figure is attributed to the 2019 trial in 40 women. It does not appear in that trial's published abstract, which reports only that improvement on ketoconazole was significant at month 6 while minoxidil was significant at months 4 and 6. The abstract also describes a "2% topical ketoconazole preparation", not a shampoo, so it may not tell you much about a product rinsed off after five minutes.

"Adding ketoconazole to finasteride beats either alone." The 2002 Indian trial had no ketoconazole-only arm, so it could not show anything about ketoconazole alone. Ten men took finasteride plus the shampoo, and the systematic review notes their result was not significantly different from finasteride plus minoxidil. What the trial did show is that every group containing finasteride beat minoxidil alone. As the review puts it, "ketoconazole efficacy was not assessed independently."

"Ketoconazole blocks DHT on the scalp." The DHT argument traces largely to a 2004 paper in Medical Hypotheses, written by a single author at a college of podiatric medicine, which proposes the mechanism and presents no trial. Oral ketoconazole at high doses does suppress steroid hormone production, which is one reason the tablets carry serious warnings. But the US prescription label for the 2% shampoo states that ketoconazole "was not detected in plasma" in 39 patients who shampooed 4 to 10 times a week for six months (DailyMed label). Any hormonal effect would have to be local to the skin, and no human study has measured one.

One more worth knowing. The 2011 pilot often quoted as "all 15 men grew hair" gave everyone a compounded lotion of finasteride, dutasteride and minoxidil. Ketoconazole shampoo was an optional extra. The authors refer to the compounded lotion as "our topical product", and their listed affiliation is a private company rather than a university or hospital.

Where ketoconazole has its best case: shedding from dandruff

The strongest evidence is for reducing shedding in men whose scalp is also inflamed by dandruff, and it is not unique to ketoconazole. In the 2002 randomised study, 150 men with pattern hair loss and dandruff-related shedding used one of three 1% anti-dandruff shampoos two to three times a week for six months.

1% shampoo	Shedding during washing	Anagen (growing) hair	Mean shaft diameter	Hair density
Ketoconazole	−17.3%	+4.9%	+5.4%	Unchanged
Piroctone olamine	−16.5%	+7.9%	+7.7%	Unchanged
Zinc pyrithione	−10.1%	+6.8%	−2.2%	Unchanged

Source: Piérard-Franchimont et al, Int J Cosmet Sci 2002.

All three shampoos cleared the dandruff and itching quickly. None changed density. Ketoconazole did no better on shedding than piroctone olamine, an ingredient found in ordinary cosmetic anti-dandruff shampoos. The systematic review's reading is that the three shampoos "improved telogen effluvium, with no significant impact" on pattern hair loss itself.

That fits the most plausible mechanism. Seborrhoeic dermatitis and dandruff inflame the scalp, and the inflammation can push extra hairs into shedding. Treat the inflammation and that extra shedding settles. It is also why the finasteride registration trials told every participant, on drug and on placebo, to use a tar-based medicated shampoo for the first two years: "to prevent seborrheic dermatitis which might confound the assessment of hair growth" (Propecia label). A flaky, itchy scalp muddies the picture, and that is a scalp problem more than a follicle problem.

The practical reading: if flaking, itching or greasy scale comes with the shedding, a medicated shampoo has a real job to do. If the scalp is calm and the hairline or crown is slowly thinning, the shampoo is aimed at a problem you may not have.

1% vs 2%: what you can buy and what the studies used

In the US, 1% ketoconazole shampoo is sold over the counter for dandruff and 2% needs a prescription. Only the 2002 study used 1%; every other human study used 2%.

The regulatory detail is odder than most pages suggest. The US generic 2% prescription labels are indicated for tinea versicolor, a fungal skin rash on the trunk, not for dandruff or hair loss (DailyMed). The over-the-counter Nizoral 1% label lists one use: to control "flaking, scaling and itching associated with dandruff" (DailyMed). In the UK the 2% strength is licensed for dandruff and seborrhoeic dermatitis (emc SmPC).

The brand's own product range makes the point. The company that now owns Nizoral in the US sells a separate "Nizoral Hair Regrowth Treatment for Men", and its active ingredient is 5% minoxidil, with "NOT FOR DANDRUFF" printed on the box (DailyMed). The company does not claim its shampoo regrows hair.

How ketoconazole shampoo was used in the studies

Most of the studies used it two to four times a week. The study abstracts rarely state a contact time; the UK label for dandruff specifies three to five minutes before rinsing.

Source	Frequency	Contact time
1998 study 1 (2%)	2 to 4 times a week	Not stated in the abstract
2002 study (1%)	2 to 3 times a week	Not stated in the abstract
Khandpur 2002 (2%, with finasteride)	3 times a week	Not stated in the abstract
US OTC Nizoral 1% label	Every 3 to 4 days for up to 8 weeks, then as needed	Lather and rinse
UK Nizoral 2% SmPC	Twice weekly for 2 to 4 weeks, then every 1 to 2 weeks to prevent recurrence	3 to 5 minutes

Two things follow. First, none of the shampoo studies used it daily except the four-man arm in 1998, and the systematic review concluded that two to three times a week "may be an adequate regimen." Second, the over-the-counter label's own directions stop at eight weeks of regular use and then drop to "as needed", and it tells users to stop and ask a doctor if the condition "does not improve in 2-4 weeks." Using it indefinitely for hair loss goes beyond what the label covers. A prescriber can say whether that makes sense for a given scalp.

Ketoconazole shampoo side effects, including hair loss

Side effects from ketoconazole shampoo are uncommon, and the UK licence data puts every listed reaction below 1%. The UK product information pools safety data from 22 clinical trials in 2,890 people and reports no adverse reaction at a rate of 1% or more (emc SmPC).

Source	What was counted	Rate
UK SmPC, 22 trials, 2,890 people	Any adverse reaction	None at 1% or above
UK SmPC frequency table	Hair loss, dry skin, abnormal hair texture, rash, burning, folliculitis, application-site irritation	"Uncommon": 1 in 1,000 to 1 in 100
UK SmPC frequency table	Acne, contact dermatitis, skin peeling, hypersensitivity	"Rare": 1 in 10,000 to 1 in 1,000
US 2% label, 11 double-blind dandruff trials, 264 patients	Increased normal hair loss and irritation	Under 1%
US 2% label, tinea versicolor trial	Drug-related adverse events	5% and 7% on shampoo vs 4% on placebo
El-Garf 2019, 20 women	Any side effect	10%, which is 2 people

The "10% of users had side effects" figure that circulates is the last row: two women in a 20-person arm, using a preparation that was not described as a shampoo.

Does ketoconazole shampoo cause hair loss? Occasionally, according to the labels. The UK product information lists alopecia as uncommon and the US label reports an increase in normal hair loss in under 1% of trial patients. Both labels also list hair discoloration and abnormal hair texture, and the US label adds that it can take the curl out of permed hair. Severe allergic reactions, including anaphylaxis, have been reported after marketing, and neither label can give a rate for them because post-marketing reports have no denominator.

Oral vs topical. In July 2013 the FDA restricted ketoconazole tablets because of serious liver injury, adrenal problems and drug interactions, and stated that "the topical formulations of ketoconazole have not been associated with liver damage, adrenal problems, or drug interactions" (FDA drug safety communication). Warnings about ketoconazole and the liver refer to the tablets, not the shampoo. Do not take ketoconazole tablets for hair loss. They are not a hair-loss treatment, and in 2016 the FDA warned doctors to stop prescribing them even for skin and nail infections after a patient died of liver damage.

Where it fits next to finasteride and minoxidil

Ketoconazole shampoo is, at most, an add-on, and the professional sources that mention it say so. The 2020 systematic review concluded that "first line therapy for androgenic alopecia remains the FDA-approved treatments of oral finasteride and topical minoxidil" and said that ketoconazole "shows promise as a low-risk adjunctive or alternative therapy", while describing the human evidence as "limited". A 2025 Canadian Delphi consensus of 11 physicians, developed with L'Oréal Canada staff among the authors, placed ketoconazole shampoo in its second tier, "recommended with near consensus", below finasteride, dutasteride, minoxidil, PRP and microneedling (J Cutan Med Surg 2025).

Here is how the three compare on the evidence itself, not the reputation.

	Finasteride 1 mg	Minoxidil 5% topical	Ketoconazole shampoo
Approved for hair loss	Yes	Yes	No
Largest placebo-controlled trials	1,553 men, two vertex trials	393 men, one 48-week trial	None
What it changes	Hair counts in trials	Hair counts in trials	Shedding and shaft diameter in small studies; density unclear
Main side effects	Sexual side effects: 3.8% vs 2.1% on placebo in year one	Itching and irritation (more at 5% than 2%), early shed, unwanted facial hair (4% of all women, drug and placebo arms combined, in pooled trials, more often on 5%)	Irritation, dryness, texture change, all under 1%

The finasteride and minoxidil numbers, and what they mean in practice, are on the finasteride vs minoxidil comparison, the minoxidil results page and in our guides to finasteride side effects and minoxidil side effects. Both drugs have side effects that the shampoo does not, which is exactly why some men look for a gentler option. The honest trade is that the gentler option also has a small fraction of the evidence.

A fair summary of what the evidence supports:

• Pattern hair loss with a calm scalp: the shampoo is not the treatment. The hair counts come from finasteride and minoxidil, and the evidence for the shampoo adding to them is one arm of ten men.
• Pattern hair loss with dandruff or seborrhoeic dermatitis: treating the scalp has a real rationale, since inflammation adds shedding and muddies whether a drug is working. A 1% ketoconazole or a piroctone olamine shampoo did about as well as each other on shedding.
• Shedding that is new, sudden or patchy: that pattern is not typical of male pattern baldness and deserves a diagnosis before any shampoo. Our guide to why minoxidil sometimes seems not to work explains why the minoxidil label excludes sudden or patchy loss.

If you are three months into finasteride and wondering whether to add something, note that at the month-three checkpoint the registration trials had not yet reported any hair-count result; that came at month six. Adding a new product then makes the next few months harder to read. Men in the 1998 studies all had vertex thinning, the pattern described on the Norwood 3 vertex page, so the results say little about a receding hairline.

Frequently Asked Questions

Does Nizoral shampoo regrow hair?

There is no good evidence that it does. The largest randomised study, 150 men over six months, found no change in hair density with 1% ketoconazole, though shedding fell by about 17%. The brand that sells Nizoral in the US markets a separate minoxidil foam for regrowth.

Is 2% ketoconazole better than 1% for hair loss?

Nobody has compared them for hair loss. Six of the seven human datasets used 2%, and the only 1% study was also the largest. It was one of only two studies to measure density, and it found no change. In the US the 2% strength needs a prescription.

Can ketoconazole shampoo make hair loss worse?

Rarely. The labels list hair loss as an uncommon reaction, under 1% in trials, alongside dryness, irritation and changes in hair texture. The OTC label advises stopping and asking a doctor if a rash appears or the scalp condition gets worse.

Can you use ketoconazole shampoo with finasteride and minoxidil?

The studies that combined them reported no significant side effects, and the shampoo is not absorbed into the blood in measurable amounts according to the US label. In one small open trial, finasteride plus ketoconazole shampoo was not significantly different from finasteride plus minoxidil, but with only 10 men in that arm the trial could not show the two were equivalent. Whether the combination adds anything is a question for the prescriber.

The bottom line

Ketoconazole shampoo is a well-tolerated antifungal with a plausible but weak case for hair loss: small, mostly non-randomised studies, a heavy industry footprint in the earliest one, and a best result that is less shedding rather than more hair. It is a reasonable scalp treatment when dandruff or seborrhoeic dermatitis is part of the picture. It is not a substitute for the drugs with trial-measured hair counts.

A dermatologist can tell whether the shedding is pattern hair loss, an inflamed scalp, or both, and that answer decides whether a medicated shampoo belongs in the plan at all. Take your Norwood stage to that appointment; it makes the conversation about the pattern, not the product.